MAKERSLPharmaceuticals
Makers Laboratories Ltd — Cash Flow Statement
₹135.20
-4.21%
Makers Laboratories Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Free Cash Flow | -8.02 Cr | -5.78 Cr | -21.53 Cr | 8.61 Cr |
| Repayment Of Debt | -8.92 Cr | -1.56 Cr | -11.74 Cr | -2.45 Cr |
| Capital Expenditure | -3.94 Cr | -6.62 Cr | -12.91 Cr | -9.89 Cr |
| End Cash Position | 0.24 Cr | 0.41 Cr | 0.72 Cr | 2.31 Cr |
| Beginning Cash Position | 0.41 Cr | 0.72 Cr | 2.31 Cr | 5.27 Cr |
| Changes In Cash | -0.17 Cr | -0.31 Cr | -1.59 Cr | -2.96 Cr |
| Financing Cash Flow | -15.84 Cr | 5.74 Cr | 5.78 Cr | 0.33 Cr |
| Net Other Financing Charges | 1.50 Cr | 6.00 Cr | -6.90 Cr | — |
| Interest Paid Cff | -1.25 Cr | -1.71 Cr | -2.12 Cr | -1.84 Cr |
| Net Issuance Payments Of Debt | -15.81 Cr | 2.24 Cr | -5.74 Cr | 2.89 Cr |
| Net Short Term Debt Issuance | -6.90 Cr | 2.64 Cr | 1.79 Cr | 5.35 Cr |
| Net Long Term Debt Issuance | -8.92 Cr | -0.40 Cr | -7.52 Cr | -2.45 Cr |
| Long Term Debt Payments | -8.92 Cr | -1.56 Cr | -11.74 Cr | -2.45 Cr |
| Investing Cash Flow | 19.75 Cr | -6.89 Cr | 1.25 Cr | -21.79 Cr |
| Net Other Investing Changes | 1.39 Cr | 1.80 Cr | 2.73 Cr | -5.60 Cr |
| Interest Received Cfi | 0.39 Cr | 0.57 Cr | 0.91 Cr | 0.70 Cr |
| Dividends Received Cfi | 4000.00 | 2000.00 | 4000.00 | 4000.00 |
| Net Investment Purchase And Sale | 3.08 Cr | -2.80 Cr | 2.85 Cr | -3.21 Cr |
| Net PPE Purchase And Sale | 14.88 Cr | -6.46 Cr | -12.50 Cr | -9.28 Cr |
| Sale Of PPE | 18.82 Cr | 0.16 Cr | 0.40 Cr | 0.61 Cr |
| Purchase Of PPE | -3.94 Cr | -6.62 Cr | -12.91 Cr | -9.89 Cr |
| Operating Cash Flow | -4.08 Cr | 0.84 Cr | -8.62 Cr | 18.50 Cr |
| Taxes Refund Paid | -2.40 Cr | -1.78 Cr | -2.47 Cr | -5.63 Cr |
| Change In Working Capital | -11.20 Cr | 0.74 Cr | -10.96 Cr | 3.23 Cr |
| Change In Other Current Liabilities | -2.66 Cr | -1.36 Cr | -0.41 Cr | 2.55 Cr |
| Change In Other Current Assets | 5.06 Cr | -3.46 Cr | -0.97 Cr | 3.14 Cr |
| Change In Payable | -5.00 Cr | 8.69 Cr | 4.56 Cr | -9.30 Cr |
| Change In Inventory | -0.23 Cr | -2.48 Cr | -7.48 Cr | 3.62 Cr |
| Change In Receivables | -8.13 Cr | -0.18 Cr | -6.49 Cr | 2.99 Cr |
| Other Non Cash Items | 0.88 Cr | 1.12 Cr | 1.24 Cr | 0.98 Cr |
| Depreciation And Amortization | 4.79 Cr | 4.54 Cr | 4.24 Cr | 4.02 Cr |
| Depreciation | 4.79 Cr | 4.54 Cr | 4.24 Cr | 4.02 Cr |
| Gain Loss On Investment Securities | -0.27 Cr | -0.01 Cr | 0.01 Cr | 0.09 Cr |
| Gain Loss On Sale Of PPE | -9.92 Cr | -0.03 Cr | -0.02 Cr | 0.05 Cr |
| Net Income From Continuing Operations | 13.41 Cr | -3.92 Cr | -0.84 Cr | 15.69 Cr |
| Issuance Of Debt | — | 1.16 Cr | 4.22 Cr | 5.35 Cr |
| Issuance Of Capital Stock | — | 0.00 | 14.75 Cr | 0.00 |
| Cash Dividends Paid | — | -0.63 Cr | -0.63 Cr | -0.63 Cr |
| Net Common Stock Issuance | — | 0.00 | 14.75 Cr | 0.00 |
| Common Stock Issuance | — | 0.00 | 14.75 Cr | 0.00 |
| Long Term Debt Issuance | — | 1.16 Cr | 4.22 Cr | 0.00 |
| Sale Of Investment | — | 2.70 Cr | 2.85 Cr | 2.38 Cr |
| Purchase Of Investment | — | -3.70 Cr | 0.00 | -5.60 Cr |
| Amortization Cash Flow | — | 0.10 Cr | — | — |
| Short Term Debt Payments | — | — | -8.90 Cr | 0.00 |
| Short Term Debt Issuance | — | — | 1.79 Cr | 5.35 Cr |
| Net Intangibles Purchase And Sale | — | — | 0.00 | 1.68 Cr |
| Sale Of Intangibles | — | — | 0.00 | 1.68 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Makers Laboratories Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.